IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VENER, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.070
NA - Nord America 4.101
AS - Asia 2.016
SA - Sud America 166
OC - Oceania 21
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.395
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.005
GB - Regno Unito 1.944
DE - Germania 1.642
CN - Cina 918
IT - Italia 771
SE - Svezia 506
SG - Singapore 480
RU - Federazione Russa 293
UA - Ucraina 264
IE - Irlanda 190
IN - India 154
KR - Corea 116
FR - Francia 112
TR - Turchia 105
FI - Finlandia 94
BR - Brasile 91
EU - Europa 91
NL - Olanda 83
CA - Canada 82
ID - Indonesia 64
VN - Vietnam 61
CO - Colombia 49
BE - Belgio 34
GR - Grecia 31
JP - Giappone 26
HK - Hong Kong 23
DK - Danimarca 21
PL - Polonia 17
AU - Australia 14
TH - Thailandia 14
AT - Austria 13
CH - Svizzera 12
AR - Argentina 11
ES - Italia 9
IL - Israele 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 7
NZ - Nuova Zelanda 7
PE - Perù 7
BD - Bangladesh 6
MX - Messico 6
IR - Iran 5
KE - Kenya 5
PK - Pakistan 5
RO - Romania 5
ZA - Sudafrica 5
EC - Ecuador 4
IQ - Iraq 4
LT - Lituania 4
PH - Filippine 4
SC - Seychelles 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
MA - Marocco 3
MK - Macedonia 3
NO - Norvegia 3
BG - Bulgaria 2
BT - Bhutan 2
CL - Cile 2
LB - Libano 2
LK - Sri Lanka 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CI - Costa d'Avorio 1
EG - Egitto 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VE - Venezuela 1
Totale 12.486
Salva come PNG Salva come JPEG
Città #
Southend 1.675
Frankfurt am Main 1.260
Boise 589
Chandler 401
Singapore 336
Milan 247
Beijing 214
Jacksonville 213
Ashburn 201
Seattle 196
Dublin 189
Princeton 189
Wilmington 170
Ann Arbor 133
Council Bluffs 114
Nanjing 109
Dearborn 107
Redmond 80
Woodbridge 76
Andover 74
Mountain View 71
Fairfield 69
Santa Clara 69
Des Moines 67
Toronto 66
Serra 65
Bengaluru 64
Sakarya 54
Bogotá 48
Houston 48
Somerville 48
Hanover 45
Payette 45
Dong Ket 43
New York 38
Shenyang 38
Garden Valley 37
Helsinki 37
Redwood City 37
Shanghai 37
Boardman 36
Jinan 35
Rome 35
Jakarta 33
Athens 30
Berlin 30
Cambridge 29
Jerome 29
Brussels 28
Nanchang 28
Changsha 24
Orofino 24
Tianjin 23
Cottonwood 21
Guangzhou 21
Saint Petersburg 20
Fuzhou 19
Lewiston 19
Los Angeles 19
Phoenix 19
Fremont 18
Grafing 18
Jiaxing 18
Kunming 18
London 18
Hebei 16
Pisa 15
San Diego 15
Zhengzhou 14
Auburn Hills 12
Medford 12
Nordman 12
São Paulo 12
Warsaw 12
Washington 12
Hong Kong 11
Kent 11
San Jose 11
Wuhan 11
Margão 10
Naples 10
Verona 10
Bitonto 9
Lanzhou 9
Quanzhou 9
Düsseldorf 8
Florence 8
Kwai Chung 8
Nürnberg 8
Roxbury 8
Como 7
Haikou 7
Kiez 7
Lima 7
Ponderay 7
Seoul 7
Eitensheim 6
Hangzhou 6
Norwalk 6
Shenzhen 6
Totale 8.550
Salva come PNG Salva come JPEG
Nome #
Low dose dasatinib in refractory imatinib mesylate chronic myeloid leukemia : case report 945
Treatment of refractory chronic GVHD with rituximab: a GITMO study 437
Istiocitosi a cellule indeterminate con evoluzione in leucemia mieloide acuta: caso clinico 288
Terapia antimicotica in un caso di mucormicosi cerebrale 256
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 245
Prognostic implications of the european consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 229
Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy 224
Caratteristiche morfologiche delle sindromi mieloproliferative croniche valutate su biopsie oesteomidollari 204
Presepsin (soluble CD14 subtype) : Reference ranges of a new sepsis marker in term and preterm neonates 196
Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis 195
Conjunctival hemorrhagic events associated with imatinib 191
First-line imatinib vs second- and third-generation TKIs for chronic-phase CML : a systematic review and meta-analysis 188
ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia 185
Reduced-intensity conditioned allogeneic transplantation for advanced mycosis fungoides and Sezary syndrome 184
The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia 175
Dasatinib induces notable cytogenetic and molecular responses in imatinib-resistant or-intolerant CML-CP 173
Low dose campath 1-H is highly effective and safe in advanced chronic CLL 170
Usefulness of Presepsin (Soluble CD14 Subtype) in the Diagnosis of Neonatal Sepsis 168
Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sézary syndrome 166
Chronic idiopathic myelofibrosis complicated by pulmonary arterial hypertension is distinctively characterized by endothelial progenitor cell insufficiency and increased angiogenesis 163
A long-term follow-up analysis in adult acute myeloid leukemia patients after hematopoietic stem cell transplantation 162
Myelodysplastic syndromes : microvascular density and immunohistochemical expression of the proteins controllin angiogenesis 161
Presepsin (Soluble CD 14 Subtype) in Term and Preterm Newborns: Preliminary Reference Ranges and Usefulness in the Diagnosis of Sepsis 161
Autologous hematopoietic stem cell transplantation : a successful treatment for early severe systemic sclerosis 157
Conjunctival hemorrhagic events associated with imatinib mesylate 157
Determining the reference range of blood presepsin in term and preterm neonates 156
Conjunctival hemorrhagic events associated with imatinib mesylate 155
TKIS IN CML : The appearance of abnormal clones in Ph- cells 154
Vascular endothelial growth factor receptor-1 (VEGFR-1) expression is increased in Ph-chronic myeloproliferative disorders and correlates with the microvessel density and VEGF 153
Abnormal clones in Philadelphia negative (Ph-) cells in CML patients treated with Imatinib mesylate 153
Incidence of leukemic transformation and second neoplasia in CMPDS PH1 151
Contribution of bone marrow derived cell angiogenesis in bcr/abl negative chronic myeloproliferative disease 150
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD 34+ cells selection 148
Multicentric Clinical Audit of Chemotherapy Administration for Lymphoprolipherative Diseases in Day Hospital Patient Setting 148
Efficacia del trattamento combinato medico e chirurgico nelle rinosinusiti fungine invasive in pazienti immunocompromessi 148
Autologous stem cell transplantation in moderate-severe refractory Crohn's disease : the Milan experience without CD34+ cells selection 147
Increased incidence of metabolic syndrome after hematopoietic stem cell transplantation 146
Immunohistochemical expression of vascular endothelial growth factor correlates with microvessel density in Ph- chronic myeloproliferative disorders 146
Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project 146
Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology 144
Autologous hematopoietic stem cell transplantation in early severe systemic sclerosis 143
Prognostic implications of the European consensus for grading of bone marrow fibrosis in primary myelofibrosis: comparison with the prognostic scoring system of the IWGMRT 138
Invasive fungal sinusitis : an effective combined treatment in five haematological patients 136
Clinical and prognostic implications of bone marrow fibrosis in chronic idiopathic myelofibrosis (CIMF) 131
Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status 130
VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders 130
Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation 127
Cytofluorimetric evaluation of B cell clonality in bone marrow of IgM MGUS 122
Early-polycythemia vera (e-PV) with thrombocytosis : clinical characteristics, morphological features and JAK2V617F mutational status contributing to the differential diagnosis with essential thrombocythemia 120
Successful surgical treatment of fungal sinusitis in onco-hematological patients 119
Clinical and biological role of vascular endothelial growth factor and its receptors in myelodysplastic syndromes 117
Correlation between microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression in myelodysplastic syndromes(MDS) 115
Initial (latent) stage of polycythaemia vera with thrombocytosis : the impact of the bone marrow biopsy and JAK2V617F mutation for the differential diagnosis with essential thrombocythaemia 113
The psychological risks associated with the non-medical switch from biologics to biosimilars 112
Possible prognostic meaning of old and recent cytokines in Hodgkin’s Lymphoma (HL) 108
Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemia 106
Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin’s disease at diagnosis 103
An acquired factor VIII inhibitor in a myeloproliferative neoplasm presenting with severe retroperitoneal hemorrhage 103
Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates 103
Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients 101
High rates of hepatitis B virus riverse seroconversion in anti-HBc carriers undergoing allogeneic bone marrow transplantation 101
Soluble cytokines in Hodgkin’s disease relate at diagnosis with disease activity and clinical stage 100
Zap-70 on bone marrow biopsy is a good prognostic indicator in B-CLL 99
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT 98
The Frequency of Cranial Base Fractures in Lethal Head Trauma 98
The European consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis 97
Modelling birthweight as a function of gestational age at delivery in hypertensive disorder of pregnancy 96
Serum levels of different cytokines in patients with Hodgkin’s disease 95
Rituximab May Allow To Improve Multi-Organ Involvement in Patients with cGVHD 93
Presepsin (Soluble {CD}14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial 93
Histological parameters and "in vitro" cultures identify different subsets of myelofibrosis with myeloid mataplasia (MMM) 92
Diagnostic value of cell bound and circulating neutrophil antibody detection in pediatric neutropenia 92
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis 91
Modelling the progression of cervical dilatation in spontaneous labour 90
Oxidative Stress Is Increased in Chronic Idiopathic Myelofibrosis (CIMF) Patients, and Is Associated with High Levels of Homocysteine (Hcy) and Depletion of Holotranscobalamin (holoTC) 87
Evaluation of coping and compliance in onco-hematological patients 87
Efficacia del voriconazolo nel trattamento di un’infezione fungina invasiva in paziente affetto da leucemia mieloide acuta (LMA) refrattaria 79
A few hints to face Covid-19 pandemic in Italy 78
The expression of cyclin D1 in multiple myeloma (MM) correlates with the degree of bone marrow infiltration and the clinical stage of disease 77
Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms 75
Il trapianto allogenico di cellule staminali emopoietiche ad intensità ridotta nei Linfomi non-Hodgkin 74
Quality of life in head and neck cancer survivors: the Big Data for Quality of Life study 72
Intensity of CD 20 expression in B-cell lymphoproliferative syndromes 65
Intensity of CD20 expression in B-cell lymphoproliferative syndromes 65
Prognostic significance of bone marrow histological dysplastic features in essential thrombocythemia 62
Role of CD79b and CD43 in the diagnosis of chronic B-cell lymphoproliferative syndromes 62
PHA-680632: Exploratory repeated IP toxicity study in the rat (Mechanistic study) (T0272) 61
Treatment of acute respiratory failure by non-invasive ventilation is feasible and effective in hematologic units 59
Il trapianto di cellule staminali emopoietiche nei linfomi indolenti 58
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma 57
Prognostic significance of bone marrow biopsy in Essential Thrombocytemia 54
Authors’ Response 54
In vitro cultures support histological parameters in the identification of different subsets of myelofibrosis with myeloid metaplasia (MMM) 48
Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation 44
Indeterminate cell histiocytosis evolving into acute myelogenous leukaemia 41
Microvessel density (MVD) and vascular endothelial growth factor (VEGF) immunohistochemical expression in Ph (-) chronic myeloproliferative disorders (CMPDS) 37
null 3
Totale 13.136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.047
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020368 0 0 0 0 0 0 0 0 0 268 67 33
2020/20211.450 98 79 95 11 122 124 148 59 138 68 309 199
2021/20221.199 132 76 92 47 80 58 135 54 149 93 42 241
2022/20231.386 175 158 145 142 155 264 37 88 135 12 53 22
2023/20241.634 29 70 44 58 162 95 190 199 96 172 238 281
2024/20251.701 219 315 170 374 196 74 45 208 100 0 0 0
Totale 13.136